Our Scientific Focus
Introduction to epitranscriptomics
Accent President Robert Copeland explains epitranscriptomics and the Accent mission to translate this extraordinary new area of biology into life-changing cancer therapies
Publications
Han, D., Lui, J., Chen, C., Dong, L., Liu, Y. ... He, C. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 566, 270-274, doi: 10.1038/s41586-019-0916-x (2019).
Buker, S.M., Boriack-Sjodin, P.A., & Copeland, R.A. Enzyme-Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality. SLAS Discovery, DOI: 10.1177/2472555219829898 (2019).
Boriack-Sjodin, P. A., Ribich, S., & Copeland, R. A. RNA-Modifying Proteins as Anticancer Drug Targets. doi:10.1038/nrd.2018.71. Nature Reviews Drug Discovery.
» View all publications